Table 2

Internal consistency reliability for the MDASI-Immunotherapy EPT at each assessment time

Time	Core	Immunotherapy EPT severity	Immunotherapy EPT interference
Baseline	0.91	0.92	0.93
Week 1	0.91	0.92	0.93
Week 2	0.91	0.92	0.92
Week 3	0.90	0.91	0.92
Week 4	0.88	0.89	0.91
Week 5	0.89	0.91	0.94
Week 6	0.89	0.90	0.93
Week 7	0.89	0.91	0.93
Week 8	0.89	0.91	0.95
Week 9	0.90	0.92	0.94

MDASI-Immunotherapy EPT, Immunotherapy for Early-Phase Trials module of the MD Anderson Symptom Inventory.